The company has brought its Japanese manufacturing technology to the USA, and claims this will help provide much biologically younger cell therapies to Americans.
The new Carlsbad facility will provide researchers with critical tools, expertise, and support to rapidly advance cell therapies toward clinical manufacturing.
